Colorectal cancer is the second-leading cause of cancer death in the U.S. Finding it early can vastly improve the chances for successful treatment, but screening rates are low, even though screening is known to be effective. But if people are reminded to be screened, or are sent in-home tests, the screening rates improve.
Time for a colonoscopy? Many want to shun this screening for colorectal cancer, but according to the US Preventive Services Task Force, having the procedure is the best way to go. This and other modalities were evaluated in their latest recommendations on CRC screening.
A New York City-based coalition of healthcare workers, physicians and community outreach specialists managed to increase the city's screening colonoscopy rate from an abysmal 42 percent in 2003, when the C5 coalition began, to an amazing 70 percent last year. A incredible boon for public health.
For the first time, the official federal health panel has recommended aspirin to protect against colorectal cancer, as well as heart attack and stroke. But the guidance is far from clear-cut, with age restrictions and numerous caveats.
A new study links long-term, continuous use of common painrelievers (NSAIDs and aspirin) to a reduced risk of colorectal cancer (CRC). This study does not prove a cause-and-effect benefit, and these drugs can cause bleeding, so discuss with your doctor.
The CDC has released its survey data on how many Americans are getting the recommended cancer screening test for cervical, breast and colorectal cancer. They believe too few are following their advice. We think the issue is more nuanced.
Sometimes more screening is better, mainly when it involves colorectal cancer and colonoscopy. Well, better screening is better, anyway: a new study shows a strong correlation between a higher detection rate of polyps and a lower subsequent cancer rate.